James Paul Rickey - Jan 4, 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC. (ALPN)

Role: Senior Vice President, Chief Financial Officer and Corporate Secretary
Signature: /s/ James Paul Rickey
Stock symbol: ALPN
Transactions as of: Jan 4, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/5/2023, 06:01 PM
Previous filing: Jan 6, 2022
Next filing: Nov 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALPN	Stock Option (Right to buy)	Award	$0	+109K		$0.00	109K	Jan 4, 2023	Common Stock	109K	$7.55	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
F2	One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.

Remarks:

Senior Vice President, Chief Financial Officer and Corporate Secretary